Since August, many patients have been experiencing a delay in treatment due to the production of TICE BCG. There has been increased worldwide demand for the drug and few manufacturers causing a backorder issue. Generally, there has been a delay in orders between 2 – 8 weeks which impacts patients, physicians and the entire bladder cancer community. We have been working with Merck to resolve this issue. The company provided an update today on their website. Click the links below to view the letter as well as the FAQ’s. FAQ from Merck 3-15 Letter from Merck 3-15 Orders may be tracked at www.merckorders.com by clicking…Read More...
Advocacy Issue – Blue Light Cystoscopy
You may have read our posting with an update on the issue regarding reimbursement of blue light cystoscopy. As all of you know, there are very few treatments and innovations for bladder cancer. It is BCAN’s position that everyone should have equal access to all treatments, tests and innovations that have been approved by the FDA. When reimbursement is restricted, it limits access for patients to care that may improve their quality of life. As a patient advocacy organization, this is an important issue to us and the bladder cancer community. This has been an ongoing issue and we are…Read More...
Moving Towards Improved Patient-Centered Research: Perspective from a John Quale Travel Fellow
As an early investigator trying to have an impact in bladder cancer, I received a John Quale Travel Fellowship to attend the 2011 BCAN Think Tank Meeting. This award has honestly had a profound impact on my personal understanding of bladder cancer and also provided me with the opportunity to advance my career. For me, this impact has been best personified by two concepts: 1. Ask important questions and 2. Work with smart and motivated people.Read More...
Saturday, May 2, 2015*
Be heard! Join the Patient Survey Network
March 27, 2015
WEBINAR: Be Heard! Join the Patient Survey Network - REGISTER NOW
WEBINAR: Caring for the Cancer Caregiver
Call for Papers
New Bladder Cancer Journal
- Bladder cancer is the sixth most commonly diagnosed cancer in the U.S.
- Nearly 75,000 new cases of bladder cancer are expected to be diagnosed in 2014.
- More than 15,000 people will die from the disease this year alone.
- Bladder cancer is three times more common in men than in women.
- One in 42 people will be diagnosed with bladder cancer during their lifetime.